In conclusion, despite the flaws in our study, for example, pure bioinformatics analysis without experimental verification, our study provides strong evidence that AKAP12 is closely related to tumor immunity in STAD from three aspects: immune infiltration cells, immune pathways, and immunomodulators. This evidence concerns the gene AKAP12 and gastric adenocarcinoma.